This inventor holds 1 USPTO granted patent. Top assignee: Evestra, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Cancer Treatment by Swapna Konda
Introduction
Swapna Konda is an accomplished inventor based in San Antonio, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on the development of novel therapeutic agents that target specific pathways involved in cancer progression.
Latest Patents
Swapna Konda holds a patent for "Orally active leukemia inhibitory factor (LIF) antagonists for the treatment of cancer." This patent describes novel LIF/LIFR inhibitors that exhibit improved cytotoxicity and bioavailability. These inhibitors are particularly useful for treating tumors associated with the overexpression of LIF. She has 1 patent to her name, showcasing her commitment to advancing cancer therapies.
Career Highlights
Konda is currently employed at Evestra, Inc., where she continues to push the boundaries of cancer research. Her work at Evestra has positioned her as a key player in the development of innovative treatments that aim to improve patient outcomes.
Collaborations
One of her notable collaborators is Gulzar Ahmed, with whom she has worked closely to advance their research initiatives. Their partnership exemplifies the collaborative spirit that drives innovation in the scientific community.
Conclusion
Swapna Konda's contributions to cancer treatment through her innovative patents and research at Evestra, Inc. highlight her role as a leading inventor in the field. Her work continues to inspire advancements in therapeutic strategies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile